SpringerLink
Log in

Consensus Linee Guida feocromocitoma/paraganglioma in pazienti portatori di varianti germinali a carico del gene SDHD

  • PROGETTI SPECIALI - CONSENSUS
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Mannelli M, Canu L, Ercolino T et al. (2018) Diagnosis of endocrine disease: SDHx mutations: beyond pheochromocytomas and paragangliomas. Eur J Endocrinol 178:R11–R17

    Article  CAS  PubMed  Google Scholar 

  2. Burnichon N, Mazzella J-M, Drui D et al. (2017) Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma. J Med Genet 54:125–133

    Article  PubMed  Google Scholar 

  3. Taïeb D, Wanna GB, Ahmad M et al. (2023) Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol 11(5):345–361

    Article  PubMed  PubMed Central  Google Scholar 

  4. Heesterman B, de Pont LM, Verbist BM et al. (2017) Age and tumor volume predict growth of carotid and vagal body paragangliomas. J Neurol Surg Part B Skull Base 78:497–505

    Article  Google Scholar 

  5. Guss ZD, Batra S, Limb CJ et al. (2011) Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys 81:e497–502

    Article  PubMed  PubMed Central  Google Scholar 

  6. Buitenwerf E, Osinga TE, Timmers HJ et al. (2020) Efficacy of alfa-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial. J Clin Endocrinol Metab 105:2381–2391

    Article  PubMed  Google Scholar 

  7. Asai S, Katabami T, Tsuiki M et al. (2017) Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas/paragangliomas. Horm Cancer 8:108–118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Baudin E, Goichot B, Berruti A et al. (2021) 567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): an academic double-blind trial investigating sunitinib. Ann Oncol 32:S621–S625

    Article  Google Scholar 

  9. Perez K, Jacene H, Hornick JL et al. (2022) SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma. Endocr-Relat Cancer 29:533–544

    Article  CAS  PubMed  Google Scholar 

  10. Lenders JW, Duh QY, Eisenhofer G et al. (2014) Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915–1942

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Biomediche Sperimentali e Cliniche Mario Serio, Università degli Studi di Firenze, Firenze, Italia

    Lorenzo Zanatta & Letizia Canu

  2. Unità di Endocrinologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italia

    Lorenzo Zanatta & Letizia Canu

Authors
  1. Lorenzo Zanatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Letizia Canu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Letizia Canu.

Ethics declarations

Conflitto di interessi

Gli autori Lorenzo Zanatta e Letizia Canu dichiarano di non avere conflitti di interesse.

Additional information

Proposto da L. Canu e M. Mannelli.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zanatta, L., Canu, L. Consensus Linee Guida feocromocitoma/paraganglioma in pazienti portatori di varianti germinali a carico del gene SDHD. L'Endocrinologo 25, 333–336 (2024). https://doi.org/10.1007/s40619-024-01468-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-024-01468-x

Search

Navigation